Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Protease-activated receptors implicated in lower urinary tract inflammation

Feb. 3, 2005

Spectrum acquires rights to RenaZorb

Feb. 3, 2005

RDP-58 active in model of interstitial cystitis

Feb. 2, 2005

Lilly withdraws duloxetine NDA for stress urinary incontinence

Feb. 2, 2005

Yamanouchi presents novel series of antidiuretic compounds

Jan. 26, 2005

Vesicare available in U.S.

Jan. 21, 2005

BMP-7 effective in preclinical models of Parkinson's disease and kidney injury

Jan. 21, 2005

TRPV1 agonist effective against urinary incontinence in preclinical model

Jan. 19, 2005

Clinical trial confirms the benefits of conivaptan in the management of hyponatremia

Jan. 18, 2005

KRX-101 phase II/III program recommended to continue to phase III

Jan. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...